Michael Findlay

7.2k total citations
111 papers, 3.3k citations indexed

About

Michael Findlay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michael Findlay has authored 111 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Michael Findlay's work include Colorectal Cancer Treatments and Studies (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cancer Treatment and Pharmacology (12 papers). Michael Findlay is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cancer Treatment and Pharmacology (12 papers). Michael Findlay collaborates with scholars based in New Zealand, Australia and United Kingdom. Michael Findlay's co-authors include David Cunningham, Pierce K. H. Chow, Anna K. Nowak, Michael J. Solomon, Tamas Hickish, B Osterwalder, Jim Cassidy, Chris Twelves, Gϋnter von Minckwitz and Andrew Wardley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michael Findlay

107 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Findlay New Zealand 29 1.6k 988 814 601 456 111 3.3k
Kentaro Yamazaki Japan 30 2.4k 1.5× 1.5k 1.5× 681 0.8× 572 1.0× 629 1.4× 278 3.7k
Giordano Beretta Italy 27 2.7k 1.6× 1.4k 1.4× 1.1k 1.4× 700 1.2× 708 1.6× 108 4.3k
Carmine Pinto Italy 30 2.3k 1.4× 1.5k 1.5× 1.2k 1.5× 351 0.6× 360 0.8× 263 3.7k
Joong Bae Ahn South Korea 35 3.1k 1.9× 1.6k 1.6× 1.4k 1.8× 992 1.7× 585 1.3× 227 4.7k
Smitha Krishnamurthi United States 25 2.2k 1.3× 939 1.0× 487 0.6× 834 1.4× 493 1.1× 126 3.3k
C. Aschele Italy 27 2.6k 1.6× 1.2k 1.2× 1.7k 2.1× 432 0.7× 471 1.0× 74 3.5k
Michael Michael Australia 36 2.2k 1.3× 1.2k 1.2× 1.3k 1.6× 805 1.3× 276 0.6× 194 4.6k
Yasutsuna Sasaki Japan 35 2.6k 1.6× 1.2k 1.3× 435 0.5× 1.2k 2.1× 455 1.0× 193 4.0k
J. S. Macdonald United States 24 2.8k 1.7× 924 0.9× 1.3k 1.6× 440 0.7× 662 1.5× 68 3.8k
D. Amadori Italy 35 1.8k 1.1× 1.1k 1.1× 701 0.9× 739 1.2× 518 1.1× 173 3.9k

Countries citing papers authored by Michael Findlay

Since Specialization
Citations

This map shows the geographic impact of Michael Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Findlay more than expected).

Fields of papers citing papers by Michael Findlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Findlay. The network helps show where Michael Findlay may publish in the future.

Co-authorship network of co-authors of Michael Findlay

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Findlay. A scholar is included among the top collaborators of Michael Findlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Findlay. Michael Findlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Burns, Kathryn, et al.. (2019). A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells. Cancer Chemotherapy and Pharmacology. 84(4). 739–748. 2 indexed citations
4.
Wilson, Michelle, et al.. (2017). Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care.. PubMed. 130(1460). 63–72. 4 indexed citations
5.
Muthukaruppan, Anita, Annette Lasham, Cherie Blenkiron, et al.. (2017). Gene expression profiling of breast tumours from New Zealand patients.. PubMed. 130(1464). 40–56. 2 indexed citations
6.
Wasan, Harpreet, Guy van Hazel, Volker Heinemann, et al.. (2017). Overall survival in the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line SIRT in patients with mCRC. Annals of Oncology. 28. x43–x44. 1 indexed citations
7.
Muthukaruppan, Anita, Annette Lasham, Kathryn J. Woad, et al.. (2016). Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors. Clinical Breast Cancer. 17(2). 139–153. 4 indexed citations
8.
9.
Mitchell, Nicola J., et al.. (2014). Transient increase in serum CEA while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?. Journal of Clinical Oncology. 32(3_suppl). 654–654. 1 indexed citations
10.
Harvey, V.J., Katrina Sharples, R. Isaacs, et al.. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology. 24(7). 1828–1834. 5 indexed citations
11.
Thompson, John, et al.. (2012). Dietary patterns and information needs of colorectal cancer patients post-surgery in Auckland.. PubMed. 125(1356). 38–46. 9 indexed citations
12.
Findlay, Michael, et al.. (2011). An application of discrete-event simulation to an outpatient healthcare clinic with batch arrivals. Winter Simulation Conference. 1166–1177. 4 indexed citations
13.
Hill, Andrew, Peter S. Bergin, Paul Thompson, et al.. (2010). Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer. 10(1). 451–451. 42 indexed citations
14.
Han, Catherine & Michael Findlay. (2010). Chemotherapy‐induced reversible posterior leucoencephalopathy syndrome. Internal Medicine Journal. 40(2). 153–159. 7 indexed citations
15.
Ritchie, David, Ian F. Hermans, Jianping Yang, et al.. (2006). Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies. Leukemia & lymphoma. 47(4). 675–682. 3 indexed citations
16.
Nowak, Anna K., Martin R. Stockler, Pierce K. H. Chow, & Michael Findlay. (2005). Use of tamoxifen in advanced‐stage hepatocellular carcinoma. Cancer. 103(7). 1408–1414. 43 indexed citations
17.
Christmas, Tim & Michael Findlay. (2004). Lung cancer treatment in New Zealand: physician's attitudes.. PubMed. 117(1196). U931–U931. 5 indexed citations
18.
Rosemergy, Ian & Michael Findlay. (2002). Phenytoin toxicity as a result of 5-fluorouracil administration.. PubMed. 115(1159). U124–U124. 7 indexed citations
19.
Rivory, Laurent P., Michael Findlay, Stephen Clarke, & James F. Bishop. (1998). Trace analysis of SN-38 in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 714(2). 355–359. 28 indexed citations
20.
Findlay, Michael, R. John Simes, Keith Cox, et al.. (1993). A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen. European Journal of Cancer. 29(3). 309–315. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Yamazaki Breakdown of academic impact, for papers by Giordano Beretta Breakdown of academic impact, for papers by Carmine Pinto Breakdown of academic impact, for papers by Joong Bae Ahn Breakdown of academic impact, for papers by Smitha Krishnamurthi Breakdown of academic impact, for papers by C. Aschele Breakdown of academic impact, for papers by Michael Michael Breakdown of academic impact, for papers by Yasutsuna Sasaki Breakdown of academic impact, for papers by J. S. Macdonald Breakdown of academic impact, for papers by D. Amadori
Rankless by CCL
2026